Literature DB >> 26435947

Amphotericin B Resistant Apophysomyces elegans Causing Rhino-oculo-Cerebral Mucormycosis in an Immunocompetent Host.

Debasis Biswas1, Aarti Kotwal2, Barnali Kakati2, Sohaib Ahmad3.   

Abstract

Mucormycosis, an angioinvasive infection is caused by the ubiquitous filamentous fungi of the order Mucorales and class Mucormycetes. Reports of this disease are on the rise over the past few decades. Rhino-oculo-Cerebral presentation associated with uncontrolled diabetes is the predominant characteristic of this entity. We report here a case of rhinooculocerebral mucormycosis (ROCM) due to Apophysomyces elegans (A. elegans) in a 45-year-old diabetic lady with background illness of hypothyroidism and polyradiculoneuropathy. Though this condition is usually managed with surgical debridement of the affected tissue and medical therapy with Amphotericin B, the isolate recovered in our case was found to be resistant to Amphotericin B.

Entities:  

Keywords:  Antifungal susceptibility profile; Diabetes; Mucormycosis

Year:  2015        PMID: 26435947      PMCID: PMC4576538          DOI: 10.7860/JCDR/2015/13929.6272

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

Review 1.  Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test.

Authors:  Janis E Blair; Lorna J Fredrikson; Barbara A Pockaj; Christina S Lucaire
Journal:  Mayo Clin Proc       Date:  2002-07       Impact factor: 7.616

2.  Fatal rhino-orbito-cerebral zygomycosis caused by Apophysomyces elegans in a healthy patient.

Authors:  Petr Schütz; Jamal H Behbehani; Zia U Khan; Suhail Ahmad; Mahmood A Kazem; Rita Dhar; Waddah Eskaf; Hussein H Hamed; Larry L Cunningham
Journal:  J Oral Maxillofac Surg       Date:  2006-12       Impact factor: 1.895

3.  In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Authors:  Nikolaos G Almyroudis; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Shimon Kusne
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

4.  Mucormycosis in immunocompetent individuals: an increasing trend.

Authors:  Suryanrayan Rao Sridhara; Gilbert Paragache; Naresh K Panda; Arunaloke Chakrabarti
Journal:  J Otolaryngol       Date:  2005-12

Review 5.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts.

Authors:  B D Alexander; W A Schell; A M Siston; C Y Rao; W A Bower; S A Balajee; D N Howell; Z S Moore; J Noble-Wang; J A Rhyne; A T Fleischauer; J M Maillard; M Kuehnert; D Vikraman; B H Collins; C E Marroquin; B J Park
Journal:  Am J Transplant       Date:  2010-08-25       Impact factor: 8.086

7.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 8.  Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.

Authors:  Kimberly P Liang; Imad M Tleyjeh; Walter R Wilson; Glenn D Roberts; Zelalem Temesgen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

  8 in total
  2 in total

1.  RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis.

Authors:  Trung Anh Trieu; María Isabel Navarro-Mendoza; Carlos Pérez-Arques; Marta Sanchis; Javier Capilla; Patricia Navarro-Rodriguez; Loida Lopez-Fernandez; Santiago Torres-Martínez; Victoriano Garre; Rosa María Ruiz-Vázquez; Francisco E Nicolás
Journal:  PLoS Pathog       Date:  2017-01-20       Impact factor: 6.823

2.  Refractory bronchovascular pleuropulmonary mucormycosis: Case report and difficulties in management.

Authors:  M Manjunath; Deepak Prajapat; Rahul Kumar Sharma; Deepak Talwar
Journal:  Lung India       Date:  2018 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.